Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | -6.73% |
|
-6.28% | -53.81% |
20/05 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
17/05 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
Evolution of the average Target Price on Entero Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Entero Therapeutics, Inc.
HC Wainwright | |
Roth Capital Partners | |
Maxim |
EPS Revisions
- Stock Market
- Equities
- ENTO Stock
- Consensus Entero Therapeutics, Inc.